Global Blood Clot Retrieval Devices Market Size By Type (Mechanical/Fragmentation Thrombectomy Devices, Stent Retrievers), By End-User (Hospitals And Surgical Centers, Ambulatory Surgical Centers), By Geographic Scope And Forecast

Blood Clot Retrieval Devices Market Size And Forecast

Blood Clot Retrieval Devices Market size is growing at a moderate pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2023 to 2030.

What's pushing the blood clot retrieval devices market? Well, a big part of it is that more people are having ischemic strokes, hemorrhagic strokes, and transient ischemic attacks because, let's face it, too many of us aren't living healthy lives. But it's not just that. Things like better reimbursement policies, the growing desire for less invasive surgeries, and the fact that strokes are becoming more common as we age are all adding fuel to the fire. Want the full story? The Global Blood Clot Retrieval Devices Market report gives you the lowdown. It breaks down all the important pieces, like key segments, emerging trends, what's driving growth, what's holding it back, who the major players are, and everything else that matters.

Global Blood Clot Retrieval Devices Market Definition

So, those devices doctors use to grab blood clots? They're often called thrombectomy devices, which is the more official term. The procedure where they actually go in and get the clot out is called a thrombectomy, and it's usually done in arteries around the heart, legs, or even in the brain. Now, a stroke happens when the brain doesn't get enough blood, causing brain cells to die. That's where blood clot retrieval comes in – it's a surgery where they physically remove the clot from the brain. This is usually for folks who've had a stroke, specifically ischemic strokes, which are the ones caused by those pesky blood clots. Think of it like a tiny plumber going in to unclog a drain!

Think of it this wayremoving a blood clot from the brain with a special device can really lower the risk of lasting problems after a stroke, like paralysis or trouble speaking. This procedure, called blood clot retrieval, is usually done for ischemic strokes, which happen when a clot blocks blood flow to the brain. Basically, a stroke is what happens when the brain doesn't get enough blood, leading to brain cell damage. There are two main typesischemic strokes, caused by blockages, and hemorrhagic strokes, caused by internal bleeding. You can learn more here.

So, if someone's having a stroke caused by a clot, getting to the hospital fast – within eight hours – is key for a treatment called clot retrieval. The actual procedure takes around two hours. These procedures use special devices, called neuro-thrombectomy devices, to remove the clot that's blocking blood flow to the brain and causing the ischemic stroke. And get thisaccording to the Centers for Disease Control and Prevention (CDC), ischemic strokes are a big deal, making up about 87% of all strokes in the US! When it comes to treating ischemic stroke, the main options are mechanical thrombectomy, where a specialist physically removes the clot with clot retrievers or suction, and thrombolytic therapy, which uses medication to dissolve the offending clot.

Global Blood Clot Retrieval Devices Market Overview

What's fueling the growth of the stroke management devices market? Well, a big part of it is the increase in strokes of all kinds – ischemic, hemorrhagic, and those scary TIAs – mainly because people are living more sedentary and unhealthy lives. Plus, better reimbursement policies are helping, and more folks are looking for minimally invasive surgery options. And let's not forget that strokes are becoming more common as our population ages. Speaking of minimally invasive, the fact that we're learning more about acute ischemic strokes and really wanting those less invasive procedures is making these devices way more popular worldwide. Just think, the American Stroke Association reports that there are over 690,000 ischemic strokes every year in the United States alone!

Some of the variables that are responsible for the expansion of the market include the availability of reimbursement policies to cover the expenses of treatment, as well as growing investments made by market participants in the research and development of innovative technologies. The COVID-19 outbreak hampered the expansion of the neuro thrombectomy devices industry. Due to a decrease in elective treatments, key competitors in the industry reported a decrease in income. Non-essential procedures were to be postponed under government rules. These modifications, combined with travel restrictions and quarantine, resulted in fewer patient visits to hospitals, resulting in fewer neurological diagnoses and neuro thrombectomy treatments conducted in the 2020-2021 period.

However, the risk of postoperative complications and the high cost of the surgical procedure, the absence of infrastructure and skilled professions, and the stringent government regulations associated with the safety and efficacy of blood clot retrieval devices all act as barriers to the market’s expansion. It is projected that ongoing research and development activities related to blood clot retrieval devices would make available new prospects for the market.

Global Blood Clot Retrieval Devices MarketSegmentation Analysis

The Global Blood Clot Retrieval Devices Market is Segmented on the basis of Type, End-User, And Geography.

Blood Clot Retrieval Devices Market, By Type

• Mechanical/Fragmentation Thrombectomy Devices
• Stent Retrievers
• Basket/Brush Retrievers
• Coil Retrievers
• Aspiration Thrombectomy Devices
• Rheolytic/Hydrodynamic Thrombectomy Devices
• Ultrasonic Thrombectomy Devices

Based on Type, the market is segmented into Mechanical/Fragmentation Thrombectomy Devices, Stent Retrievers, Basket/Brush Retrievers, Coil Retrievers, Aspiration Thrombectomy Devices, Rheolytic/Hydrodynamic Thrombectomy Devices, and Ultrasonic Thrombectomy Devices. Aspiration devices and clot retrievers are the two primary subcategories that make up this sector of the worldwide market. Because of its superior clinical outcomes, the clot retrievers subsegment dominated the global market and is anticipated to have considerable growth over the course of the forecast period.

These tools are currently dominating the market as a result of their cutting-edge technology as well as the ease and safety with which they may be utilized in the process of eliminating clots from the brain’s smaller blood veins. During the time period under consideration, it is predicted that the aspiration devices segment will record a higher CAGR. The expansion of this market niche can be attributed to the fact that the process of removing blood clots from a patient using aspiration devices takes significantly less time than employing clot retrievers does. These devices are utilized to remove huge blood clots that are clogging the veins and assist in reducing the amount of embolization that occurs.

Blood Clot Retrieval Devices Market, By End-User

• Hospitals and Surgical Centers
• Ambulatory Surgical Centers
• Research Laboratories & Academic Institutes
• Other End Users

Based on End-User, the market is segmented into Hospitals and Surgical Centers, Ambulatory Surgical Centers, Research Laboratories & Academic Institutes, and Other End Users. As of the year 2020, the hospital sector owned the lion’s share of the global market. This was mostly attributable to the fact that stroke treatment should be administered in an environment that is well-equipped. Stroke treatment should be received within 24 hours of the onset of symptoms in order to prevent stroke disability.

In addition, a thorough brain scan should be performed in a hospital setting in order to confirm the type of stroke that has occurred. On the other hand, it is predicted that the category representing specialist clinics would record a somewhat higher CAGR over the course of the forecast year. It is due to the dedicated stroke units that have highly qualified physicians, the most recent technologically updated equipment, and infrastructure that includes a rehabilitation facility for patients once they have completed their treatment that the market is growing.

Blood Clot Retrieval Devices Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Geography, the Blood Clot Retrieval Devices Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. in 2021, Increased government spending on healthcare infrastructure in the Asia Pacific will boost the target market. India, China, and Australia all massively invest in infrastructure to better serve their citizens. India is advancing, as seen by the Union Budget’s investment. In India, the healthcare sector is rapidly evolving. Changing government policies, more investment, and acquisitions all help the medical sector grow.

Players worldwide are drawn to developing economies for their raw commodities and cheap labor. Favorable government policies and increased alliances between regional and international businesses will drive this market. Due to stroke mortality, Europe had the second-largest Blood Clot Retrieval Devices Market. North America’s revenue share will also grow due to rapid medical device technical advancements. In wealthy countries, thrombectomies and embolectomies have increased.

Key Players

The “Global Blood Clot Retrieval Devices Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Johnson and Johnson, Terumo Corporation, Teleflex Incorporated, Boston Scientific Corp, Bayer, Penumbra, AngioDynamics, Argon Medical Devices, and Medtronic Plc. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• Penumbra, Inc. got FDA approval in June 2021 for its RED 62 Reperfusion Catheter, which will be used to navigate and provide aspiration to remove blood clots in acute ischemia patients with major artery occlusions.
• In April 2019, Medtronic introduced the Solitaire (TM) X Revascularization Device in the United States, which is used to physically remove blood clots from blood arteries and restore revascularization rate in patients with acute ischemic stroke.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.